WASL_HUMAN - dbPTM
WASL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID WASL_HUMAN
UniProt AC O00401
Protein Name Neural Wiskott-Aldrich syndrome protein
Gene Name WASL
Organism Homo sapiens (Human).
Sequence Length 505
Subcellular Localization Nucleus . Cytoplasm . Cytoplasm, cytoskeleton . Preferentially localized in the cytoplasm when phosphorylated and in the nucleus when unphosphorylated. Exported from the nucleus by an nuclear export signal (NES)-dependent mechanism to the cytoplasm.
Protein Description Regulates actin polymerization by stimulating the actin-nucleating activity of the Arp2/3 complex. Involved in mitosis and cytokinesis, via its role in the regulation of actin polymerization. Binds to HSF1/HSTF1 and forms a complex on heat shock promoter elements (HSE) that negatively regulates HSP90 expression. Plays a role in dendrite spine morphogenesis (By similarity)..
Protein Sequence MSSVQQQPPPPRRVTNVGSLLLTPQENESLFTFLGKKCVTMSSAVVQLYAADRNCMWSKKCSGVACLVKDNPQRSYFLRIFDIKDGKLLWEQELYNNFVYNSPRGYFHTFAGDTCQVALNFANEEEAKKFRKAVTDLLGRRQRKSEKRRDPPNGPNLPMATVDIKNPEITTNRFYGPQVNNISHTKEKKKGKAKKKRLTKADIGTPSNFQHIGHVGWDPNTGFDLNNLDPELKNLFDMCGISEAQLKDRETSKVIYDFIEKTGGVEAVKNELRRQAPPPPPPSRGGPPPPPPPPHNSGPPPPPARGRGAPPPPPSRAPTAAPPPPPPSRPSVAVPPPPPNRMYPPPPPALPSSAPSGPPPPPPSVLGVGPVAPPPPPPPPPPPGPPPPPGLPSDGDHQVPTTAGNKAALLDQIREGAQLKKVEQNSRPVSCSGRDALLDQIRQGIQLKSVADGQESTPPTPAPTSGIVGALMEVMQKRSKAIHSSDEDEDEDDEEDFEDDDEWED
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSSVQQQPP
------CCCCCCCCC
38.9419413330
15PhosphorylationPPPPRRVTNVGSLLL
CCCCCCCCCCCCEEE
23.5227273156
19PhosphorylationRRVTNVGSLLLTPQE
CCCCCCCCEEECCCC
16.1527251275
23PhosphorylationNVGSLLLTPQENESL
CCCCEEECCCCCCCH
23.93-
58PhosphorylationADRNCMWSKKCSGVA
HCCCCCCCCCCCCEE
8.71-
62PhosphorylationCMWSKKCSGVACLVK
CCCCCCCCCEEEEEC
45.2229759185
95PhosphorylationLLWEQELYNNFVYNS
EEEEEEHHHCCCCCC
13.80-
100PhosphorylationELYNNFVYNSPRGYF
EHHHCCCCCCCCCEE
13.0427642862
102PhosphorylationYNNFVYNSPRGYFHT
HHCCCCCCCCCEEEC
9.7824719451
132MalonylationEEAKKFRKAVTDLLG
HHHHHHHHHHHHHHH
50.7926320211
135PhosphorylationKKFRKAVTDLLGRRQ
HHHHHHHHHHHHHHH
26.28-
170PhosphorylationDIKNPEITTNRFYGP
ECCCCCCCCCCCCCC
19.1621945579
171PhosphorylationIKNPEITTNRFYGPQ
CCCCCCCCCCCCCCC
30.0221945579
175PhosphorylationEITTNRFYGPQVNNI
CCCCCCCCCCCCCCC
25.3421945579
183PhosphorylationGPQVNNISHTKEKKK
CCCCCCCCCCCHHHC
27.5128985074
185PhosphorylationQVNNISHTKEKKKGK
CCCCCCCCCHHHCCC
33.8225159151
186UbiquitinationVNNISHTKEKKKGKA
CCCCCCCCHHHCCCC
63.2132015554
205PhosphorylationLTKADIGTPSNFQHI
CCCCCCCCCCCCCCC
24.7125159151
207PhosphorylationKADIGTPSNFQHIGH
CCCCCCCCCCCCCEE
50.5525627689
242PhosphorylationLFDMCGISEAQLKDR
HHHHHCCCHHHHCCC
16.5016257963
251PhosphorylationAQLKDRETSKVIYDF
HHHCCCCHHHHHHHH
34.4428152594
252PhosphorylationQLKDRETSKVIYDFI
HHCCCCHHHHHHHHH
21.8528152594
253UbiquitinationLKDRETSKVIYDFIE
HCCCCHHHHHHHHHH
39.8229967540
256PhosphorylationRETSKVIYDFIEKTG
CCHHHHHHHHHHHHC
14.0519664994
261UbiquitinationVIYDFIEKTGGVEAV
HHHHHHHHHCCHHHH
47.8829967540
274MethylationAVKNELRRQAPPPPP
HHHHHHHHCCCCCCC
50.03115484371
284MethylationPPPPPPSRGGPPPPP
CCCCCCCCCCCCCCC
60.92115367429
305MethylationGPPPPPARGRGAPPP
CCCCCCCCCCCCCCC
40.91115484361
307MethylationPPPPARGRGAPPPPP
CCCCCCCCCCCCCCC
32.3324129315
329MethylationPPPPPPSRPSVAVPP
CCCCCCCCCCCCCCC
33.03115484351
426PhosphorylationLKKVEQNSRPVSCSG
HHCHHHCCCCCCCCC
37.3429255136
430PhosphorylationEQNSRPVSCSGRDAL
HHCCCCCCCCCHHHH
12.7830266825
432PhosphorylationNSRPVSCSGRDALLD
CCCCCCCCCHHHHHH
29.3830266825
449PhosphorylationRQGIQLKSVADGQES
HHCCCCEECCCCCCC
31.0022199227
456PhosphorylationSVADGQESTPPTPAP
ECCCCCCCCCCCCCC
38.0222199227
457PhosphorylationVADGQESTPPTPAPT
CCCCCCCCCCCCCCC
32.3222199227
460PhosphorylationGQESTPPTPAPTSGI
CCCCCCCCCCCCCHH
33.0322199227
464PhosphorylationTPPTPAPTSGIVGAL
CCCCCCCCCHHHHHH
41.5122199227
465PhosphorylationPPTPAPTSGIVGALM
CCCCCCCCHHHHHHH
26.0122199227
479PhosphorylationMEVMQKRSKAIHSSD
HHHHHHHHHHHCCCC
33.2125072903
484PhosphorylationKRSKAIHSSDEDEDE
HHHHHHCCCCCCCCC
33.1128176443
485PhosphorylationRSKAIHSSDEDEDED
HHHHHCCCCCCCCCC
30.7528176443

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
242SPhosphorylationKinaseTNK2Q07912
Uniprot
256YPhosphorylationKinaseABL2Q4JIM5
GPS
256YPhosphorylationKinaseTNK2Q07912
Uniprot
256YPhosphorylationKinasePTK2Q05397
GPS
484SPhosphorylationKinasePAK4O96013
PSP
485SPhosphorylationKinasePAK4O96013
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
242SPhosphorylation

16257963
484SPhosphorylation

20068231
485SPhosphorylation

20068231

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of WASL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SRC8_HUMANCTTNphysical
11830518
NCK1_HUMANNCK1physical
11340081
RHOQ_HUMANRHOQphysical
12456725
CDC42_HUMANCDC42physical
10781580
GRB2_HUMANGRB2physical
10781580
PROF1_HUMANPFN1physical
9822597
WIPF1_HUMANWIPF1physical
12372256
A4_HUMANAPPphysical
21832049
WIPF2_HUMANWIPF2physical
22939629
ZN638_HUMANZNF638physical
22939629
HS90A_BOVINHSP90AA1physical
15791211
HS90B_BOVINHSP90AB1physical
15791211
HS90A_HUMANHSP90AA1physical
15791211
HS90B_HUMANHSP90AB1physical
15791211
ARC1B_HUMANARPC1Bphysical
15894313
ARP2_HUMANACTR2physical
12732638
ARP3_HUMANACTR3physical
12732638
WIPF1_HUMANWIPF1physical
11331876
ZN395_HUMANZNF395physical
21988832
GELS_HUMANGSNphysical
16531231
RNF8_HUMANRNF8physical
25416956
ARPC3_HUMANARPC3physical
25416956
RHOJ_HUMANRHOJphysical
25416956
FBP1L_HUMANFNBP1Lphysical
26344197
CIP4_HUMANTRIP10physical
26344197
WASF1_HUMANWASF1physical
26344197
WASF2_HUMANWASF2physical
26344197
WASF3_HUMANWASF3physical
26344197
RNF8_HUMANRNF8physical
21516116
WIPF2_HUMANWIPF2physical
28514442
WIPF3_HUMANWIPF3physical
28514442
WIPF1_HUMANWIPF1physical
28514442
ATG4C_HUMANATG4Cphysical
28514442
ACTBL_HUMANACTBL2physical
28514442
ACY2_HUMANASPAphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of WASL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484 AND SER-485, ANDMASS SPECTROMETRY.
"Phosphorylation of WASP by the Cdc42-associated kinase ACK1: dualhydroxyamino acid specificity in a tyrosine kinase.";
Yokoyama N., Lougheed J., Miller W.T.;
J. Biol. Chem. 280:42219-42226(2005).
Cited for: PHOSPHORYLATION AT SER-242 AND TYR-256 BY TNK2, AND INTERACTION WITHWASL.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-256, AND MASSSPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-256, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-256, AND MASSSPECTROMETRY.

TOP